191 related articles for article (PubMed ID: 20385428)
1. The place of downstaging for hepatocellular carcinoma.
Toso C; Mentha G; Kneteman NM; Majno P
J Hepatol; 2010 Jun; 52(6):930-6. PubMed ID: 20385428
[TBL] [Abstract][Full Text] [Related]
2. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
Sharr WW; Chan SC; Lo CM
Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma downstaging in liver transplantation.
Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
[TBL] [Abstract][Full Text] [Related]
4. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
[TBL] [Abstract][Full Text] [Related]
5. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for hepatocellular carcinoma.
Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
Cescon M; Cucchetti A; Ravaioli M; Pinna AD
J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatocellular carcinoma.
Blum HE
Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the management of hepatocellular carcinoma.
Schwartz M; Roayaie S; Konstadoulakis M
Nat Clin Pract Oncol; 2007 Jul; 4(7):424-32. PubMed ID: 17597707
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: trans-arterial radio-embolisation of HCC.
Andreana L; Isgrò G; Marelli L; Davies N; Yu D; Navalkissoor S; Burroughs AK
Cancer Treat Rev; 2012 Oct; 38(6):641-9. PubMed ID: 22169503
[TBL] [Abstract][Full Text] [Related]
11. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
Barakat O; Wood RP; Ozaki CF; Ankoma-Sey V; Galati J; Skolkin M; Toombs B; Round M; Moore W; Mieles L
Liver Transpl; 2010 Mar; 16(3):289-99. PubMed ID: 20209588
[TBL] [Abstract][Full Text] [Related]
12. General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?
Fujiki M; Aucejo F; Kim R
Liver Int; 2011 Sep; 31(8):1081-9. PubMed ID: 22008644
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
14. Downstaging hepatocellular carcinoma prior to liver transplantation.
Gamblin TC; Geller DA
Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
[No Abstract] [Full Text] [Related]
15. [Therapy of hepatocellular carcinoma].
Allgaier HP; Deibert P; Blum U; Spangenberg HC; Moser E; Blum HE
Schweiz Med Wochenschr; 1996 Nov; 126(46):1984-94. PubMed ID: 8984607
[TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation.
Kulik LM; Atassi B; van Holsbeeck L; Souman T; Lewandowski RJ; Mulcahy MF; Hunter RD; Nemcek AA; Abecassis MM; Haines KG; Salem R
J Surg Oncol; 2006 Dec; 94(7):572-86. PubMed ID: 17048240
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
18. Downstaging of bilobar hepatocellular carcinoma after radioembolization with
Reguera-Berenguer L; Orcajo-Rincón J; Rotger-Regí A; Matilla-Peña AM; Echenagusia-Boyra M; Pérez-Pascual R; Marí-Hualde A; Alonso-Farto JC
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):329-332. PubMed ID: 28268101
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatocellular carcinoma.
Giuliani F; Colucci G
Oncology; 2009; 77 Suppl 1():43-9. PubMed ID: 20130431
[TBL] [Abstract][Full Text] [Related]
20. Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation.
Troisi R; Defreyne L; Hesse UJ; Praet M; Decruyenaere J; De Hemptinne B
Clin Transplant; 1998 Aug; 12(4):313-9. PubMed ID: 9686325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
